Independent Director · Cardiff Oncology, Inc. (CRDF)

James O. Armitage director compensation at Cardiff Oncology: $176K

Fiscal year 2025 director compensation for James O. Armitage at Cardiff Oncology, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 23, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get James O. Armitage’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track James O. Armitage and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Cardiff Oncology Director Compensation Table · all 3 fiscal years held
In US dollars, as Cardiff Oncology reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$69,000$0$106,670$0$175,670
FY2024$69,000—$56,460—$125,460
FY2023$69,000—$35,434—$104,434

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cardiff Oncology, Inc. DEF 14A filed April 23, 2026, accession 0001213037-26-000006, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Cardiff Oncology, Inc. filed document, accession 0001213037-26-000006. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2026.

Get the Cardiff Oncology Board Governance Report

$175,670 James O. Armitage, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 23, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Cardiff Oncology pays directors a $65,000 cash retainer and $106,670 in Options.

Committees

FY2025 · as the proxy prints them

Audit · Nominating/Governance

The rest of the Cardiff Oncology board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Gary W. PaceIndependent Director$184,170
Lale WhiteIndependent Director$189,170
Mani MohindruDirector$183,670
Renee P. TannenbaumIndependent Director$181,670
Rodney S. MarkinIndependent Director$225,670

The full Cardiff Oncology compensation record

free company brief

This page is one director within Cardiff Oncology's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Cardiff Oncology proxy · each links to its own free brief

Order CRDF

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report